DISCUSSION: Our case reiterates the importance of differentiating a person with multiple lung masses as having SPLC rather than a single primary with metastatic disease. SPLC continues to pose unique diagnostic and management challenges. Literature review suggests that surgical resection has been attempted in patients presenting with SPLC depending on stage and histopathology of individual primaries. However, 5-year survival was only 20 % in patients undergoing surgery. For non-surgical candidates, stereotactic body radiation, conventional radiation, percutaneous image-guided tumor ablation and adjuvant chemotherapy has been tried.